NCT00468884View on ClinicalTrials.gov

Oral Administration of Peptides; Absorption From Gastrointestinal Tract

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

February 28, 2007

Conditions
Healthy
Interventions
DRUG

Increasing doses of GLP-1

DRUG

PYY3-36

Trial Locations (1)

CH-4031

Clinical Research Centre, University Hospital, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT00468884 - Oral Administration of Peptides; Absorption From Gastrointestinal Tract | Biotech Hunter | Biotech Hunter